{"abstract": "The company, which increased its earnings guidance for the year, blamed the recalls of its brand-name medicines for lower third-quarter sales", "web_url": "https://www.nytimes.com/2010/10/20/business/20drug.html", "snippet": "The company, which increased its earnings guidance for the year, blamed the recalls of its brand-name medicines for lower third-quarter sales", "lead_paragraph": "A series of recalls of Tylenol and other popular brand-name medicines this year is largely to blame for a decline in third-quarter sales at Johnson & Johnson to $15 billion, a decrease of 0.7 percent, the company said on Tuesday.", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sales Decline, but Earnings Rise for Johnson & Johnson", "kicker": null, "content_kicker": null, "print_headline": "Sales Decline, but Earnings Rise for Johnson & Johnson", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Company Reports", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 3, "major": "N"}], "pub_date": "2010-10-19T22:04:47+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Natasha Singer", "person": [{"firstname": "Natasha", "middlename": null, "lastname": "Singer", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/867cae0c-5f93-59e2-ad42-0300aa4cd082", "word_count": 663, "uri": "nyt://article/867cae0c-5f93-59e2-ad42-0300aa4cd082"}